Aberrant Activation of Androgen Receptor in a New Neuropeptide-Autocrine Model of Androgen-Insensitive Prostate Cancer

Cancer Research - United States
doi 10.1158/0008-5472.can-08-0442
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Sigma1 Targeting to Suppress Aberrant Androgen Receptor Signaling in Prostate Cancer

Cancer Research
Cancer ResearchOncology
2017English

Androgen Receptor Corepressors and Prostate Cancer

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2006English

The Androgen Receptor and Prostate Cancer Invasion

Molecular and Cellular Endocrinology
BiochemistryEndocrinologyMolecular Biology
2006English

Aberrant E2F Activation by Polyglutamine Expansion of Androgen Receptor in SBMA Neurotoxicity

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2009English

New Strategies in Metastatic Prostate Cancer: Targeting the Androgen Receptor Signaling Pathway

Clinical Cancer Research
Cancer ResearchOncology
2011English

Collateral Resistance to Taxanes in Enzalutamide-Resistant Prostate Cancer Through Aberrant Androgen Receptor and Its Variants

Cancer Science
Cancer ResearchMedicineOncology
2018English

Expression and Function of Stromal Androgen Receptor in Prostate Cancer

2013English

Hypoxia Increases Androgen Receptor Activity in Prostate Cancer Cells

Cancer Research
Cancer ResearchOncology
2006English

Lupeol, a Novel Androgen Receptor Inhibitor: Implications in Prostate Cancer Therapy

Clinical Cancer Research
Cancer ResearchOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy